HKU Scholars Hub: Browsing DSpace

Browsing by Author Buti, M

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 中

or enter first few letters:

Showing results 1 to 7 of 7

	Title	Author(s)	Issue Date	Views
	Bone and Renal Safety Are Improved in Chronic HBV Patients 1 Year after Switching to Tenofovir Alafenamide (TAF) from Tenofovir Disoproxil Fumarate (TDF) Proceeding/Conference:Hepatology	Seto, WKW Buti, M Izumi, N Lim, YS Kao, JH Streinu-Cercel, A Nurmukhametova, E Ma, X Tabak, F Jablkowski, M Suri, V Flaherty, JF Lau, AH Gaggar, A Mo, S Chowdhury, A Fung, SK Chuang, WL Gane, EJ	2018	29
	IDDF2019-ABS-0168 Bone and renal safety are improved in chronic hbv patients 1 year after switching to tenofovir alafenamide (TAF) from tenofovir disoproxil fumarate (TDF) Proceeding/Conference:Gut	Lik Yuen Chan, H Seto, WKW Buti, M Izumi, N Lim, Y Kao, J Streinu-Cercel, A Nurmukhametova, E Ma, X Tabak, F Jablkowski, M Suri, V Flaherty, J Lau, A Gaggar, A Mo, S Chowdhury, A Fung, S Chuang, W Gane, E	2019
	Real-world rates of hepatitis B surface antigen (HBsAg) seroclearance in patients with chronic hepatitis B (CHB): a systematic review, conventional aggregated data meta-analysis (ADMA) and individual patient data meta-analysis (IPDMA) Proceeding/Conference:Gastroenterology	Yeo, YH Ho, HJ Yang, HI Tseng, TC Kwak, M-S Park, YM Fung, JYY Buti, M Rodriguez, M Treeprsertsuk, S Preda, CM Ungtrakul, T Charatcharoenwithaya, P Li, X Le, MH Wei, B Zou, B Le, AK Jeong, D Chien, N Kam, L Hosaka, T Riveiro, M Proca, D Suzuki, F Kobayashi, M Sriprayoon, T Chong, Y Tanwandee, T Yuen, RMF Lee, H-S Kao, J-H Lok, A Wu, C-Y Nguyen, MH	2018	8
	Sa1483 - Real-World Rates of Hepatitis B Surface Antigen (HBSAG) Seroclearance in Patients with Chronic Hepatitis B (CHB): A Systematic Review, Conventional Aggregated Data Meta-Analysis (ADMA) and Individual Patient Data Meta-Analysis (IPDMA) Proceeding/Conference:Gastroenterology	Yeo, YH Ho, HJ Yang, HI Tseng, TC Kwak, MS Park, YM Fung, JYY Buti, M Rodriguez, M Treeprasertsuk, S Preda, CM Ungtrakul, T Charatcharoenwitthaya, P Li, XY Le, MH Wei, B Zou, BY Le, AK Jeong, D Chien, N Kam, L Hosakh, T Rivetro, M Proca, D Suzuki, F Kobayashi, M Sriprayoon, T Chong, Y Tanwandee, T Yuen, RMF Lee, HS Kao, JH Lok, A Wu, CY Nguyen, MH	2018	36
	Telbivudine improves renal function in patients with chronic hepatitis B Journal:Gastroenterology	Gane, EJ Deray, G Liaw, YF Lim, SG Lai, CL Rasenack, J Wang, Y Papatheodoridis, G Di Bisceglie, A Buti, M Samuel, D Uddin, A Bosset, S Trylesinski, A	2014	59
	Tenofovir alafenamide versus tenofovir disoproxil fumarate for the treatment of patients with HBeAg-negative chronic hepatitis B virus infection: a randomised, double-blind, phase 3, non-inferiority trial Journal:The Lancet Gastroenterology & Hepatology	Buti, M Gane, E Seto, WKW Chan, HL Chuang, WL Stepanova, T Hui, AJ Lim, YS Mehta, R Janssen, H Acharya, SK Flaherty, J Massetto, B Cathcart, AL Kim, K Gaggar, A Subramanian, GM McHutchison, J Pan, C Brunetto, M Izumi, N Marcellin, P	2016	53
	Three Year Efficacy and Safety of Tenofovir Alafenamide (TAF) Compared to Tenofovir Disoproxil Fumarate (TDF) in Hbeag-Negative and Hbeag-Positive Patients with Chronic Hepatitis B Proceeding/Conference:Hepatology	Chan, HLY Lim, YS Seto, WKW Agarwal, K Brunetto, MR Janssen, HLA Caruntu, F Stepanova, T Tsang, O Yatsuhashi, H Tak, WY Chen, CY Celen, M Sun, V Flaherty, JF Lin, L Cathcart, A Gaggar, A Pan, CQ Shalimar Buti, M	2018	141

Showing results 1 to 7 of 7